These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

445 related items for PubMed ID: 20566893

  • 1. Targeting of DEC-205 on human dendritic cells results in efficient MHC class II-restricted antigen presentation.
    Birkholz K, Schwenkert M, Kellner C, Gross S, Fey G, Schuler-Thurner B, Schuler G, Schaft N, Dörrie J.
    Blood; 2010 Sep 30; 116(13):2277-85. PubMed ID: 20566893
    [Abstract] [Full Text] [Related]

  • 2. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide.
    Bonehill A, Heirman C, Tuyaerts S, Michiels A, Zhang Y, van der Bruggen P, Thielemans K.
    Cancer Res; 2003 Sep 01; 63(17):5587-94. PubMed ID: 14500399
    [Abstract] [Full Text] [Related]

  • 3. Mannose receptor targeting of tumor antigen pmel17 to human dendritic cells directs anti-melanoma T cell responses via multiple HLA molecules.
    Ramakrishna V, Treml JF, Vitale L, Connolly JE, O'Neill T, Smith PA, Jones CL, He LZ, Goldstein J, Wallace PK, Keler T, Endres MJ.
    J Immunol; 2004 Mar 01; 172(5):2845-52. PubMed ID: 14978085
    [Abstract] [Full Text] [Related]

  • 4. Antibody-targeted NY-ESO-1 to mannose receptor or DEC-205 in vitro elicits dual human CD8+ and CD4+ T cell responses with broad antigen specificity.
    Tsuji T, Matsuzaki J, Kelly MP, Ramakrishna V, Vitale L, He LZ, Keler T, Odunsi K, Old LJ, Ritter G, Gnjatic S.
    J Immunol; 2011 Jan 15; 186(2):1218-27. PubMed ID: 21149605
    [Abstract] [Full Text] [Related]

  • 5. Messenger RNA-electroporated dendritic cells presenting MAGE-A3 simultaneously in HLA class I and class II molecules.
    Bonehill A, Heirman C, Tuyaerts S, Michiels A, Breckpot K, Brasseur F, Zhang Y, Van Der Bruggen P, Thielemans K.
    J Immunol; 2004 Jun 01; 172(11):6649-57. PubMed ID: 15153480
    [Abstract] [Full Text] [Related]

  • 6. Targeting human dendritic cells via DEC-205 using PLGA nanoparticles leads to enhanced cross-presentation of a melanoma-associated antigen.
    Saluja SS, Hanlon DJ, Sharp FA, Hong E, Khalil D, Robinson E, Tigelaar R, Fahmy TM, Edelson RL.
    Int J Nanomedicine; 2014 Jun 01; 9():5231-46. PubMed ID: 25419128
    [Abstract] [Full Text] [Related]

  • 7. A polyclonal anti-vaccine CD4 T cell response detected with HLA-DP4 multimers in a melanoma patient vaccinated with MAGE-3.DP4-peptide-pulsed dendritic cells.
    Zhang Y, Renkvist N, Sun Z, Schuler-Thurner B, Glaichenhaus N, Schuler G, Boon T, van der Bruggen P, Colau D.
    Eur J Immunol; 2005 Apr 01; 35(4):1066-75. PubMed ID: 15756643
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance.
    Bonifaz L, Bonnyay D, Mahnke K, Rivera M, Nussenzweig MC, Steinman RM.
    J Exp Med; 2002 Dec 16; 196(12):1627-38. PubMed ID: 12486105
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The C-type lectin receptor CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3+ myeloid dendritic cells.
    Schreibelt G, Klinkenberg LJ, Cruz LJ, Tacken PJ, Tel J, Kreutz M, Adema GJ, Brown GD, Figdor CG, de Vries IJ.
    Blood; 2012 Mar 08; 119(10):2284-92. PubMed ID: 22234694
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of melanoma growth by targeting of antigen to dendritic cells via an anti-DEC-205 single-chain fragment variable molecule.
    Johnson TS, Mahnke K, Storn V, Schönfeld K, Ring S, Nettelbeck DM, Haisma HJ, Le Gall F, Kontermann RE, Enk AH.
    Clin Cancer Res; 2008 Dec 15; 14(24):8169-77. PubMed ID: 19088032
    [Abstract] [Full Text] [Related]

  • 14. Single-step antigen loading and activation of dendritic cells by mRNA electroporation for the purpose of therapeutic vaccination in melanoma patients.
    Bonehill A, Van Nuffel AM, Corthals J, Tuyaerts S, Heirman C, François V, Colau D, van der Bruggen P, Neyns B, Thielemans K.
    Clin Cancer Res; 2009 May 15; 15(10):3366-75. PubMed ID: 19417017
    [Abstract] [Full Text] [Related]

  • 15. Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen delivery.
    Schnurr M, Chen Q, Shin A, Chen W, Toy T, Jenderek C, Green S, Miloradovic L, Drane D, Davis ID, Villadangos J, Shortman K, Maraskovsky E, Cebon J.
    Blood; 2005 Mar 15; 105(6):2465-72. PubMed ID: 15546948
    [Abstract] [Full Text] [Related]

  • 16. The human cancer antigen mesothelin is more efficiently presented to the mouse immune system when targeted to the DEC-205/CD205 receptor on dendritic cells.
    Wang B, Kuroiwa JM, He LZ, Charalambous A, Keler T, Steinman RM.
    Ann N Y Acad Sci; 2009 Sep 15; 1174():6-17. PubMed ID: 19769731
    [Abstract] [Full Text] [Related]

  • 17. Enhancement of the priming efficacy of DNA vaccines encoding dendritic cell-targeted antigens by synergistic toll-like receptor ligands.
    Grossmann C, Tenbusch M, Nchinda G, Temchura V, Nabi G, Stone GW, Kornbluth RS, Uberla K.
    BMC Immunol; 2009 Aug 03; 10():43. PubMed ID: 19650904
    [Abstract] [Full Text] [Related]

  • 18. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination.
    Bonifaz LC, Bonnyay DP, Charalambous A, Darguste DI, Fujii S, Soares H, Brimnes MK, Moltedo B, Moran TM, Steinman RM.
    J Exp Med; 2004 Mar 15; 199(6):815-24. PubMed ID: 15024047
    [Abstract] [Full Text] [Related]

  • 19. KBMA Listeria monocytogenes is an effective vector for DC-mediated induction of antitumor immunity.
    Skoberne M, Yewdall A, Bahjat KS, Godefroy E, Lauer P, Lemmens E, Liu W, Luckett W, Leong M, Dubensky TW, Brockstedt DG, Bhardwaj N.
    J Clin Invest; 2008 Dec 15; 118(12):3990-4001. PubMed ID: 19033668
    [Abstract] [Full Text] [Related]

  • 20. Functional analysis of tumor-specific Th cell responses detected in melanoma patients after dendritic cell-based immunotherapy.
    Schultz ES, Schuler-Thurner B, Stroobant V, Jenne L, Berger TG, Thielemanns K, van der Bruggen P, Schuler G.
    J Immunol; 2004 Jan 15; 172(2):1304-10. PubMed ID: 14707109
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.